NewAmsterdam Pharma Company
NAMS
$20.09
Share price
0.20%
Change (1 day)
68.82%
Change (1 year)
Categories
NewAmsterdam Pharma Company (NAMS) - P/B ratio
P/B ratio as of May 2024 : 6.26
According to NewAmsterdam Pharma Company's latest financial reports the company has a price-to-book ratio of 6.26.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
NewAmsterdam Pharma Company - P/B ratio (from 2023 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.19 | 56.44% |
| 2022-12-31 | 2.04 | |
| 2021-12-31 | N/A |